Keyan Wu

800 total citations
36 papers, 544 citations indexed

About

Keyan Wu is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Keyan Wu has authored 36 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 10 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Keyan Wu's work include Pancreatitis Pathology and Treatment (12 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Keyan Wu is often cited by papers focused on Pancreatitis Pathology and Treatment (12 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Keyan Wu collaborates with scholars based in China, United States and Japan. Keyan Wu's co-authors include Yanbing Ding, Weiming Xiao, Guotao Lu, Weijuan Gong, Bin Deng, Jian Wu, Qingtian Zhu, Dan Wang, Weiwei Chen and Xiaolei Shi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Gene.

In The Last Decade

Keyan Wu

34 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keyan Wu China 16 222 177 135 103 88 36 544
Youming Ding China 14 246 1.1× 158 0.9× 114 0.8× 88 0.9× 73 0.8× 39 581
Huanchen Sha China 16 153 0.7× 254 1.4× 118 0.9× 102 1.0× 50 0.6× 34 555
Yinghong Zhu China 14 361 1.6× 82 0.5× 130 1.0× 90 0.9× 60 0.7× 34 682
Lei Yan China 10 248 1.1× 130 0.7× 75 0.6× 88 0.9× 47 0.5× 40 569
Zhen Ni China 13 288 1.3× 180 1.0× 70 0.5× 95 0.9× 48 0.5× 27 624
Yanbin Wang China 14 258 1.2× 158 0.9× 242 1.8× 131 1.3× 103 1.2× 49 771
Cristina Di Giorgio Italy 16 221 1.0× 154 0.9× 286 2.1× 206 2.0× 91 1.0× 36 648
Xufeng Guo China 16 276 1.2× 105 0.6× 135 1.0× 59 0.6× 54 0.6× 37 733
Patrick Hu United States 11 247 1.1× 216 1.2× 109 0.8× 39 0.4× 94 1.1× 30 672

Countries citing papers authored by Keyan Wu

Since Specialization
Citations

This map shows the geographic impact of Keyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyan Wu more than expected).

Fields of papers citing papers by Keyan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyan Wu. The network helps show where Keyan Wu may publish in the future.

Co-authorship network of co-authors of Keyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Keyan Wu. A scholar is included among the top collaborators of Keyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyan Wu. Keyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yu, Yanyan Zhao, Keyan Wu, Ziliang Wang, & Zhifeng Chen. (2025). Study on Tobacco Donations in China: An Analysis Based on Tobacco Industry Literature. 3(1). 107–118. 1 indexed citations
2.
Chen, Yu, et al.. (2025). Marketing behind charity: Media narratives of tobacco industry donations in China. Tobacco Induced Diseases. 23(October). 1–9.
3.
4.
Zhu, Qingtian, Chenchen Yuan, Dan Wang, et al.. (2024). The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis. Molecular Therapy. 32(9). 3025–3041. 4 indexed citations
5.
Zhang, Junxian, et al.. (2023). CD177 Inhibits Neutrophil Extracellular Trap Formation and Protects against Acute Pancreatitis in Mice. Journal of Clinical Medicine. 12(7). 2533–2533. 5 indexed citations
6.
Shi, Xiaolei, Keyan Wu, Qingtian Zhu, et al.. (2023). Elevated serum HbA1c level, rather than previous history of diabetes, predicts the disease severity and clinical outcomes of acute pancreatitis. BMJ Open Diabetes Research & Care. 11(1). e003070–e003070. 4 indexed citations
7.
Zhang, Zhilin, Lin Shi, Keyan Wu, et al.. (2022). Apigenin regulates the migration, invasion, and autophagy of hepatocellular carcinoma cells by downregulating YAP. Neoplasma. 69(2). 292–302. 9 indexed citations
8.
Yuan, Chenchen, Qingtian Zhu, Junxian Zhang, et al.. (2022). Paeonol protects against acute pancreatitis by inhibiting M1 macrophage polarization via the NLRP3 inflammasomes pathway. Biochemical and Biophysical Research Communications. 600. 35–43. 20 indexed citations
9.
Zeng, Jing, et al.. (2022). Prognostic significance of CKS2 and CD47 expression in patients with gastric cancer who underwent radical gastrectomy. Scandinavian Journal of Immunology. 96(4). e13198–e13198. 6 indexed citations
10.
11.
Wu, Keyan, Sen Han, Guotao Lu, et al.. (2020). Astilbin combined with lipopolysaccharide induces IL-10-producing regulatory B cells via the STAT3 signalling pathway. Biomedicine & Pharmacotherapy. 129. 110450–110450. 15 indexed citations
12.
Zhou, Wei, Qin Shen, Hui Wang, et al.. (2020). Knockdown of YAP/TAZ Inhibits the Migration and Invasion of Fibroblast Synovial Cells in Rheumatoid Arthritis by Regulating Autophagy. Journal of Immunology Research. 2020(1). 9510594–9510594. 29 indexed citations
13.
Han, Sen, Zhijie Lin, Keyan Wu, et al.. (2020). Astilbin promotes the induction of regulatory NK1.1− CD4+ NKG2D+ T cells through the PI3K, STAT3, and MAPK signaling pathways. International Immunopharmacology. 81. 106143–106143. 10 indexed citations
14.
Ding, Yanbing, Min Zhang, Lisheng Wang, et al.. (2019). Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis. Lipids in Health and Disease. 18(1). 93–93. 15 indexed citations
15.
Zhou, Wei, Keyan Wu, Hui Wang, et al.. (2019). <p>Silencing of TAZ inhibits the motility of hepatocellular carcinoma cells through autophagy induction</p>. Cancer Management and Research. Volume 11. 8743–8753. 3 indexed citations
16.
Wang, Dan, Xiaoping Yu, Weiming Xiao, et al.. (2018). Prevalence and clinical characteristics of fatty pancreas in Yangzhou, China: A cross-sectional study. Pancreatology. 18(3). 263–268. 27 indexed citations
17.
Wu, Keyan, Qingtian Zhu, Weiming Xiao, et al.. (2018). Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway. Mediators of Inflammation. 2018. 1–12. 75 indexed citations
18.
Xiao, Weiming, Keyan Wu, Min Yin, et al.. (2015). Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor Immunity. Journal of Immunotherapy. 38(5). 167–184. 22 indexed citations
19.
Ding, Yanbing, Yu Liang, Bin Deng, et al.. (2014). Induction of TGF-β and IL-10 production in dendritic cells using astilbin to inhibit dextran sulfate sodium-induced colitis. Biochemical and Biophysical Research Communications. 446(2). 529–534. 25 indexed citations
20.
Ding, Yanbing, Bin Deng, Weiming Xiao, et al.. (2013). A High Level of Integrin α6 Expression in Human Intrahepatic Cholangiocarcinoma Cells Is Associated with a Migratory and Invasive Phenotype. Digestive Diseases and Sciences. 58(6). 1627–1635. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youming Ding Breakdown of academic impact, for papers by Huanchen Sha Breakdown of academic impact, for papers by Yinghong Zhu Breakdown of academic impact, for papers by Lei Yan Breakdown of academic impact, for papers by Zhen Ni Breakdown of academic impact, for papers by Yanbin Wang Breakdown of academic impact, for papers by Cristina Di Giorgio Breakdown of academic impact, for papers by Xufeng Guo Breakdown of academic impact, for papers by Patrick Hu
Rankless by CCL
2026